Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Cellmark UK Forensic Contracts Extended

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark today announced the two-year extension of contracts previously awarded under the North West/South West and Wales regional forensic tender process in the UK.

The contracts, originally awarded in April 2008, were set to expire in 2011 and have been extended to 2013. In total, the contracts have a value of about $10 million, the company said in a statement.

The forensic testing contracts are for three areas — comprehensive casework services using a range of forensic analytical methods; DNA testing of crime scene samples for submission to the National DNA Database; and DNA testing of samples from arrested criminal suspects.

In the tender, Orchid was awarded work from nine UK police forces in Avon & Somerset; Cumbria; Devon & Cornwall; Dorset; Dyfed Powys; Greater Manchester; Lancashire; Merseyside; and North Wales.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.